Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial

The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis

William P. Arend, Beat A. Michel, D. Blöch et al. · Arthritis & Rheumatism · 1990 · 2.3K citations

Medicine, Clinical Sciences, Internal Medicine +10

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Raashid Luqmani, P A Bacon, Robert J. Moots et al. · PubMed · 1994 · 1.1K citations

Medicine, Clinical Sciences, Internal Medicine +17

Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients

Kathleen Maksimowicz‐McKinnon, Tiffany Clark, Gary S. Hoffman · Arthritis & Rheumatism · 2007 · 507 citations

Medicine, Clinical Sciences, Internal Medicine +11

Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

Gary S. Hoffman, Peter A. Merkel, Richard Brasington et al. · Arthritis & Rheumatism · 2004 · 423 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease

João Tomé‐Carneiro, Mar Larrosa, María J. Yáñez‐Gascón et al. · Pharmacological Research · 2013 · 373 citations

Medicine, Cardiology, Nutritional Sciences +17